Abstract:BACKGROUND & OBJECTIVE:A proliferation-inducing ligand (APRIL), a new member of the tumor necrosis factor (TNF) family, can stimulate tumor cell growth and proliferation both in vitro and in vivo. This research was to detect the expression of APRIL in colorectal carcinoma tissues, and to compare the effects of 5-fluorouracil (5-FU) and cisplatin (DDP) on the expression of APRIL in colorectal carcinoma SW480 cells. METHODS:The protein and mRNA levels of APRIL in 56 specimens of human colorectal carcinoma and para-tumor tissues and in SW480 cells were determined by immunohistochemistry and real-time fluorescence quantitative reverse transcription-polymerase chain reaction (FQ-RT-PCR). SW480 cells were treated with 5-FU and DDP at various concentrations for 24 h, 48 h and 72 h. The changes of APRIL mRNA level were analyzed by FQ-RT-PCR. RESULTS:Both positive rate and mRNA level of APRIL were significantly higher in colorectal carcinoma tissues than in para-tumor tissues (76.8% vs. 16.1%, 0.16+/-0.05 vs. 0.71+/-0.08, both P<0.001). The expression of APRIL was strong in SW480 cells. When treated with different concentrations of 5-FU, the mRNA level of APRIL in SW480 cells raised gradually and reached the highest levels at 72 h after treatment (0.85+/-0.10, 0.81+/-0.09, 0.83+/-0.11, and 0.90+/-0.12 at the concentrations of 25, 50, 100 and 200 microg/mL, respectively), which were significantly higher than those in blank control group (P<0.001). When treated with different concentrations of DDP, the mRNA level of APRIL in SW480 cells did not increase when compared with that in control group (P>0.05). After 72-hour treatment, the mRNA level of APRIL in SW480 cells was significantly lower in 10 microg/mL and 20 microg/mL DDP groups than in blank control group (0.44+/-0.05 and 0.40+/-0.07 vs. 0.57+/-0.06, P<0.05). CONCLUSIONS:APRIL may promote the development of colorectal carcinoma. When chemotherapy is conducted to treat colorectal carcinoma, especially when 5-FU is included in the regimen, anti-APRIL therapy might be an important assistant treatment to counter the impact of APRIL caused by antitumor drugs.

Pl4ARF and E2F1 Suppress Human Colorectal Tumorigenesis

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

[Expression of APRIL in Colorectal Carcinoma Tissues and Effects of Chemotherapeutic Agents on APRIL Expression in Colorectal Carcinoma SW480 Cells].

P14arf Interacts with E2F Factors to Form P14arf–e2f/partner‐dna Complexes Repressing E2F‐dependent Transcription

Transfection of Lipofectin-meidated P14arf Gene into Human Pancreatic Cancer Cells

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

P14~(ARF) Signaling Pathway

Expression of MDM2,P53 and P14ARF in human colon cancer

P14ARF: The Absence that Makes the Difference

Clinicopathological Significance of P14arf Expression in Lung Cancer: a Meta-Analysis.

Effects of P14arf Gene on Angiogenesis of Pancreatic Carcinoma

Expression of EGFR,Grb2,p-mTOR and VEGF in Human Colorectal Cancer Tissues

Expression of P14ARF in cervical carcinoma and precancerous lesion and its relationship with HPV infection

Paf15 Expression Correlates With Rectal Cancer Prognosis, Cell Proliferation And Radiation Response

E2F1 Promote the Aggressiveness of Human Colorectal Cancer by Activating the Ribonucleotide Reductase Small Subunit M2

Transfection of Wild-Type P14arf Gene Leads to Growth Inhibition of Human Lung Cancer Cell Lines

Study on the Expression and Relationship of P14arf Protein and P53 Protein in Human Glioma

Role of RAS Association Domain Family 1,Isoform A(RASSF1A) in Suppression of Proliferation in Human Esophageal Carcinoma EC9706 Cells

Expression of Epidermal Growth Factor and Epidermal Growth Factor-Receptor and its Significance in Colorectal Cancer

Anti-Tumor Effects of Paeoniflorin on Epithelial-To-Mesenchymal Transition in Human Colorectal Cancer Cells.

Effects of p14ARF gene on the invasion of pancreatic carcinoma in vitro